Inovio Pharmaceuticals
INO
#9183
Rank
NZ$0.18 B
Marketcap
NZ$2.71
Share price
1.24%
Change (1 day)
-24.13%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): NZ-$4.80

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$4.79. In 2024 the company made an earnings per share (EPS) of NZ-$6.57 an increase over its 2023 EPS that were of NZ-$10.13.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.80-26.86%
2024NZ-$6.57-35.14%
2023NZ-$10.13-56.62%
2022NZ-$23.35-19.54%
2021NZ-$29.0235.9%
2020NZ-$21.35-11.57%
2019NZ-$24.1515.24%
2018NZ-$20.95-2.78%
2017NZ-$21.556.93%
2016NZ-$20.16134.88%
2015NZ-$8.58-29.51%
2014NZ-$12.17-57.34%
2013NZ-$28.54146.55%
2012NZ-$11.5720.83%
2011NZ-$9.58-29.41%
2010NZ-$13.57-48.48%
2009NZ-$26.3410%
2008NZ-$23.9511.11%
2007NZ-$21.55-41.3%
2006NZ-$36.72-66.91%
2005NZ-$110.96110.61%
2004NZ-$52.68-61.63%
2003NZ-$137.30186.67%
2002NZ-$47.89
2001N/A-100%
2000NZ-$38.32-63.64%
1999NZ-$105.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$17.36-462.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.24-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.86-159.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$10.84-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.63-363.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.98-224.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
NZ-$2.08-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA